Hélène Donnadieu-Rigole1,2,3, Nathalie Pansu4, Thibault Mura5, Stéphanie Pelletier6, Régis Alarcon6, Lucie Gamon5, Pascal Perney3,6, Florence Apparailly2,7, Jean-Philippe Lavigne3,8,9, Catherine Dunyach-Remy8,9. 1. Department of Addictology, Saint-Eloi Hospital, CHRU Montpellier, Montpellier, France. 2. INSERM, U1183, IRMB, Saint-Eloi Hospital, CHRU Montpellier, Montpellier, France. 3. University of Montpellier, Montpellier, France. 4. Department of Infectious Diseases, Saint Eloi Hospital, CHRU Montpellier, Montpellier, France. 5. Department of Medical Information, La Colombière Hospital, Montpellier, France. 6. Department of Addictology, CHU Carémeau, Nîmes, France. 7. Department for Osteoarticular Diseases, University Hospital Lapeyronie, Montpellier, France. 8. Department of Microbiology, CHU Caremeau, Nîmes, France. 9. INSERM, U1047, Caremeau Hospital, Nîmes, France.
Abstract
BACKGROUND: The human intestinal microbiota exerts beneficial or harmful effects in several disorders. Many factors, including alcohol consumption, may influence its composition and trigger bacterial translocation. Excessive alcohol consumption increases gut permeability and translocation of endotoxin into peripheral circulation. Although plasma endotoxin concentrations have been measured often, quantitative changes following alcohol withdrawal have never been described in subjects with alcohol use disorder (AUD). The aim of this study was to measure microbial translocation (MT) and gut permeability markers in patients with AUD, to compare these markers to healthy controls (HC) and to monitor markers during the first 6 weeks of abstinence. METHODS: Sixty-five patients with AUD and hospitalized for alcohol withdrawal were included. Epidemiological, clinical, biological, and addictological data were gathered. Blood samples were collected at baseline, then 3 and 6 weeks after alcohol withdrawal. A hundred healthy volunteers were used as controls. Three markers of MT were monitored in plasma samples: sCD14 and lipopolysaccharide-binding protein (LBP) were quantified using ELISA, and 16S rDNA was quantified using real-time polymerase chain reaction. Zonulin and intestinal fatty acid binding protein (I-FABP) blood levels were also monitored as indirect markers of gut permeability, using ELISA. RESULTS: At baseline, LBP, 16S rDNA, sCD14 and I-FABP markers were significantly higher in patients with AUD than in HC. Six weeks after alcohol withdrawal plasma levels of sCD14 and LBP decreased significantly. Cannabis consumption and body mass index (BMI) before alcohol withdrawal influenced baseline MT levels and the decrease in MT markers after 6 weeks. Finally, markers of MT and gut permeability did not correlate with each other before and after alcohol withdrawal. CONCLUSIONS: Before alcohol withdrawal, MT markers were higher in patients with AUD than in HC. After 6 weeks of abstinence, an improvement in MT markers was observed. Our data suggest that there is a link between MT, its improvement, BMI, and cannabis consumption.
BACKGROUND: The human intestinal microbiota exerts beneficial or harmful effects in several disorders. Many factors, including alcohol consumption, may influence its composition and trigger bacterial translocation. Excessive alcohol consumption increases gut permeability and translocation of endotoxin into peripheral circulation. Although plasma endotoxin concentrations have been measured often, quantitative changes following alcohol withdrawal have never been described in subjects with alcohol use disorder (AUD). The aim of this study was to measure microbial translocation (MT) and gut permeability markers in patients with AUD, to compare these markers to healthy controls (HC) and to monitor markers during the first 6 weeks of abstinence. METHODS: Sixty-five patients with AUD and hospitalized for alcohol withdrawal were included. Epidemiological, clinical, biological, and addictological data were gathered. Blood samples were collected at baseline, then 3 and 6 weeks after alcohol withdrawal. A hundred healthy volunteers were used as controls. Three markers of MT were monitored in plasma samples: sCD14 and lipopolysaccharide-binding protein (LBP) were quantified using ELISA, and 16S rDNA was quantified using real-time polymerase chain reaction. Zonulin and intestinal fatty acid binding protein (I-FABP) blood levels were also monitored as indirect markers of gut permeability, using ELISA. RESULTS: At baseline, LBP, 16S rDNA, sCD14 and I-FABP markers were significantly higher in patients with AUD than in HC. Six weeks after alcohol withdrawal plasma levels of sCD14 and LBP decreased significantly. Cannabis consumption and body mass index (BMI) before alcohol withdrawal influenced baseline MT levels and the decrease in MT markers after 6 weeks. Finally, markers of MT and gut permeability did not correlate with each other before and after alcohol withdrawal. CONCLUSIONS: Before alcohol withdrawal, MT markers were higher in patients with AUD than in HC. After 6 weeks of abstinence, an improvement in MT markers was observed. Our data suggest that there is a link between MT, its improvement, BMI, and cannabis consumption.
Authors: Adam W Carrico; Emily M Cherenack; Margaret E Roach; Elise D Riley; Olorunleke Oni; Samantha E Dilworth; Steven Shoptaw; Peter Hunt; Sabita Roy; Suresh Pallikkuth; Savita Pahwa Journal: AIDS Date: 2018-03-27 Impact factor: 4.177
Authors: Thaddeus M Barney; Andrew S Vore; Sarah L Trapp; Cristal L Finkenberg; Dominique R Pugliesi; Megha M Schmalzle; Shani H Evans; Elena I Varlinskaya; Terrence Deak Journal: Neuropharmacology Date: 2022-03-24 Impact factor: 5.273
Authors: Pablo Giménez-Gómez; Mercedes Pérez-Hernández; Esther O'Shea; Javier R Caso; David Martín-Hernandez; Luis Alou Cervera; María Luisa Gómez-Lus Centelles; María Dolores Gutiérrez-Lopez; Maria Isabel Colado Journal: FASEB J Date: 2019-09-11 Impact factor: 5.191